| 000 | 01787 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250511185853.0 | ||
| 264 | 0 | _c19930224 | |
| 008 | 199302s 0 0 eng d | ||
| 022 | _a0025-7931 | ||
| 024 | 7 |
_a10.1159/000196081 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRammeloo, R H | |
| 245 | 0 | 0 |
_aTherapeutic equivalence of a fenoterol/ipratropium bromide combination (Berodual) inhaled as a dry powder and by metered dose inhaler in chronic obstructive airway disease. _h[electronic resource] |
| 260 |
_bRespiration; international review of thoracic diseases _c1992 |
||
| 300 |
_a322-6 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdministration, Inhalation |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAnalysis of Variance |
| 650 | 0 | 4 |
_aBronchodilator Agents _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFenoterol _xadministration & dosage |
| 650 | 0 | 4 |
_aForced Expiratory Volume _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIpratropium _xadministration & dosage |
| 650 | 0 | 4 |
_aLung Diseases, Obstructive _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNebulizers and Vaporizers |
| 650 | 0 | 4 | _aPowders |
| 650 | 0 | 4 |
_aRespiratory Function Tests _xstatistics & numerical data |
| 650 | 0 | 4 | _aTherapeutic Equivalency |
| 650 | 0 | 4 |
_aVital Capacity _xdrug effects |
| 700 | 1 | _aLuursema, P B | |
| 700 | 1 | _aSips, A P | |
| 700 | 1 | _aBeumer, H M | |
| 700 | 1 | _aWald, F D | |
| 700 | 1 | _aCornelissen, P J | |
| 773 | 0 |
_tRespiration; international review of thoracic diseases _gvol. 59 _gno. 6 _gp. 322-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000196081 _zAvailable from publisher's website |
| 999 |
_c1495052 _d1495052 |
||